Concepedia
Clinical Therapeutics · 2003 · 102 citations · 23 references
MedicinePharmacologyPharmacotherapyAndrologyErectile DysfunctionPenile DisordersSexual DysfunctionSide EffectsCrossover DesignationPatient Preference MeasurementPde5 InhibitorsReplicate Crossover Study DesignTadalafil Therapy
23
The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences
Aytaç, Mckinlay, Krane · British Journal of Urology · 1999 · 1.3K citations
Medicine, Health Policy, Urology +12
Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission
Jacob Rajfer, William J. Aronson, Margaret A. Bush et al. · New England Journal of Medicine · 1992 · 1K citations · Full text
Life Sciences, Pharmacology, Physiology +10
Efficacy and Safety of Tadalafil for the Treatment of Erectile Dysfunction: Results of Integrated Analyses
Gerald Brock, Chris G. McMahon, K.K. Chen et al. · The Journal of Urology · 2002 · 542 citations
Medicine, Pharmacotherapy, Urology +8
Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunction
Álvaro Morales, Clive Gingell, Michael Collins et al. · International Journal of Impotence Research · 1998 · 465 citations
Medicine, Pharmacology, Pharmacotherapy +11
Health-related quality of life in men with erectile dysfunction
Mark S. Litwin, Robert J. Nied, Nasreen Dhanani · Journal of General Internal Medicine · 1998 · 305 citations · Full text
Medicine, Health Sciences, Urology +14